Submit your abstract for SDRI 2017!

We're pleased to announce that the inaugural SDRI conference will take place in Brisbane, Australia from 3–5 April 2017. Submit your abstract today!

For decades, Asia Pacific countries have played a leading worldwide role in research in antimicrobial drug discovery, molecular diagnosis and infectious diseases.

SDRI 2017 is a multi-disciplinary scientific conference for the Asia Pacific region focused on Solutions for Drug-Resistant Infections. This inaugural conference theme is New Drugs for Drug-Resistant Infections. The conference will take place at the Brisbane Convention and Exhibition Centre in Australia from 3–5 April, 2017.

The program is expected to attract 400 international participants and will provide a fantastic forum for researchers and industry representatives working in the space of microbiology, virology, parasitology, genomics, pharmacology and medicinal chemistry, to network and discuss new ways to solve the global challenge of drug-resistant infections. Our goal for SDRI 2017 is to lead a concerted discussion to set three priorities and guide research efforts towards global solutions for drug resistance research.

Submit your oral abstract today

Abstract submission deadline: 14 October 2016

With a host of world-class speakers and a sunny Australia location, SDRI 2017 promises to be an inspiring conference – and you can be part of it.

Don’t miss out on your chance to showcase your latest research alongside speakers such as:

Plenary Speakers

Over the last six years England’s Chief Medical Officer, Dame Sally Davies, has been working tirelessly on awareness and action on AMR, with the support of many other governments, organisations and programmes. Join Dame Sally and CDDEP Health Economist and AMR expert Professor Ramanan Laminarayan next April in Brisbane for SDRI 2017 conference.

Professor Sally Davies
Chief Medical Officer (CMO) for England

latest CMO picture v2

Professor Ramanan Laxminarayan
Public Health Foundation of India

MANO9251 V2

Confirmed Speakers:

Dr Manica Balasegaram
GARD Partnership Operations, DNDi

Professor Tania de Koning-Ward
Deakin University

Associate Professor Heidi Drummer
Drummer/Poumbourios Laboratory, Burnet Institute

Professor Ian Gilbert
Drug Discovery Unit, University of Dundee

Professor Bob Hancock
Department of Microbiology and Immunology, The University of British Columbia (UBC)

Dr Timothy Jinks
Wellcome Trust

Professor Anne Kelso (tentative)
National Health and Medical Research Council

Dr Line Matthiessen
Health European Commission - DG Research & Innovation

Dr Nicola Petty
University of Technology Sydney

Dr Kade Roberts
Li Lab, Monash University

Dr Terry Roemer
Head of Antimicrobial Discovery, Merck

Dr David Shlaes
Anti-infectives Consultant

Associate Professor Gilda Tachedjian
Burnet Institute

Professor Man-Wah Tan

Dr Tony Velkov
Monash University

Professor Gerry Wright
Michael G. DeGroote Institute for Infectious Disease Research

Dr Michelle Wykes
QIMR Berghofer Medical Research Institute

Dr Zuoyu Xu
National Institute of Allergy and Infectious Diseases

SDRI 2017 Session themes

Registration is now open

We look forward to welcoming you to Queensland in 2017.


Professor Matthew Cooper
Co-Chair SDRI 2017
Director of the Centre for Superbug Solutions
Institute for Molecular Bioscience
The University of Queensland

Jian V2

Professor Jian Li
Co-Chair SDRI 2017
Monash Biomedicine Discovery Institute
Monash University

Key dates

Abstract submission deadline - 14 October 2016
Earlybird deadline - 9 December 2016
Conference dates - 3 - 5 April 2017

Our Sponsors

logo BCLS Vertical

Corning Logo 301Blue 6in

eurofins Pharma Discovery Services V2

RCG LogoStacked2


IMB logo CMYK institute name 01

b anwc Oceanic rgb

Go to the profile of Community for Open Antimicrobial Drug Discovery

Community for Open Antimicrobial Drug Discovery

CO-ADD, Not-for-profit research initiative

CO-ADD is a not-for-profit initiative led by academics at The University of Queensland (Australia). Our goal is to screen compounds from academic research groups from anywhere in the world for free, and utilize their chemical diversity to discover novel compounds active against bacteria or fungi. We aim to engage and help researchers around the world to find new, diverse compounds to combat the superbug crisis.

No comments yet.